Organization · Venture Capital
Kurma Partners
Kurma Partners is a Paris-based venture capital firm specializing in healthcare and biotechnology investments across Europe. They manage approximately €890 million and focus on supporting early-stage companies and collaborating with research centers.
Overview
What Kurma Partners does
What Kurma Partners is
Kurma Partners is a Paris-based venture capital firm specializing in healthcare and biotechnology investments across Europe. They manage approximately €890 million and focus on supporting early-stage companies and collaborating with research centers.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2009
- Approximate age
- About 17 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Kurma Partners elsewhere
Open the official website or a supported primary organization account.
Capability profile
Kurma Partners as a funder
Investment thesis
Kurma Partners focuses on funding healthcare and biotechnology companies in Europe, investing at various stages from creation to capital expansion.
Focus narrative
Kurma Partners primarily invests in the healthcare and biotechnology sectors, employing a strategy that encompasses various stages of company maturity. Their focus includes biotherapies, diagnostics, and deep tech, allowing them to support a diverse range of innovative solutions in the life sciences.
Value beyond capital
Kurma Partners adds value to its portfolio companies by leveraging its extensive network and expertise in the healthcare and biotechnology sectors. The firm collaborates closely with its companies, providing strategic guidance and access to leading research institutions to accelerate innovation and growth.
Focus and fit
- Stages
- Friends and Family · Angel · Accelerator · Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity · Pre-IPO · Ipo
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 72
Portfolio context
Kurma Partners boasts a diverse portfolio of notable companies, including Adcytherix, Altamira Therapeutics, Alveus Therapeutics, Amolyt Pharma, Cardiologs, DNA Script, Ganymed Robotics, ImCheck, Pharvaris, and Xeltis. These companies are engaged in various areas within biotechnology, health technology, and diagnostics.
Common questions
What to know about Kurma Partners
Upseed classifies Kurma Partners under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.